COMMUNIQUÉS West-GlobeNewswire

Verrica Pharmaceuticals to Present YCANTH® and VP-315 Data at Two Upcoming Dermatology Conferences
10/09/2026
– Post-hoc analysis shows YCANTH ® drove high rates of complete clearance in molluscum contagiosum patients regardless of disease duration – WEST CHESTER, Pa., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals [...]
Instinct Science Announces Attending, a First-of-Its-Kind Clinical AI Assistant Built Exclusively for Veterinarians
10/09/2026
Attending is the only veterinary AI assistant grounded in peer-reviewed, continually updated references, including Plumb’s Veterinary Drugs. PHILADELPHIA, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Instinct Science , the [...]
MAIA Biotechnology Delivers Oral and Poster Presentations Showcasing Next-Generation Telomere-Targeting Cancer Therapies at IRT 2026
10/09/2026
Next-generation divalent agents show increased anticancer activity in preclinical in vitro and in vivo models CHICAGO, Sept. 10, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “ [...]
Oncolytics Biotech® Announces Positive Preclinical Results Combining Pelareorep with a Pan-RAS Inhibitor in Colorectal Cancer
10/09/2026
Preclinical results demonstrate pelareorep activity is maintained in the presence of RAS inhibition Findings support further evaluation of pelareorep’s potential to deepen and prolong responses to RAS-targeted therapy [...]
SS Innovations Provides Update on Continuing Progress and Milestones
10/09/2026
-- Advancing global expansion, pediatric robotic surgery and telesurgery -- -- Growing SSi Mantra installations, procedures and utilization -- FORT LAUDERDALE, Fla., Sept. 10, 2026 (GLOBE NEWSWIRE) -- via IBN -- SS [...]
Quoin Pharmaceuticals Releases New NETHERTON NOW Video: Aminah’s Story Featuring Laura Wright-Sexton, MD, the Physician Who First Met Her Daughter in the ICU
10/09/2026
This New Video Explores the Daily Realities of Raising a Child with Netherton Syndrome, and Its Impact on the Whole Family ASHBURN, Va., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“ [...]
BioCardia to Present CardiAMP Regulatory and Corporate Progress at H.C. Wainwright 28th Annual Global Investment Conference
10/09/2026
SUNNYVALE, Calif., Sept. 10, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced [...]
Intelligent Bio Solutions to Host Virtual Fireside Chat on September 24th at 4:30 p.m. ET
10/09/2026
Management to discuss FDA 510(k) submission, clinical data, and commercial progress outside the U.S. NEW YORK, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), [...]
Military Veteran Alpine Challenge Marks Five Years of Supporting Veterans Living with Chronic Pain
10/09/2026
MONT-TREMBLANT, Québec, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Nine Canadian military Veterans living with chronic pain reached the summit at Mont-Tremblant, Quebec on September 9, completing a 10-kilometre climb for the [...]
Historic First in MS Treatment Could Reshape a Multibillion-Dollar Therapeutics Market
10/09/2026
AUSTIN, Texas, Sept. 10, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage : Today's multiple sclerosis treatments can slow down disease progression, but none of them halt it outright, and none give back the [...]
Vistagen to Present at Psych Congress 2026
10/09/2026
Poster presentation highlights positive efficacy signal for fasedienol nasal spray in study participants with very severe social anxiety disorder SOUTH SAN FRANCISCO, Calif., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Vistagen [...]
SeaStar Medical to Present at the HC Wainwright 28th Annual Global Investment Conference
10/09/2026
DENVER, Sept. 10, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transformational treatments for critically ill patients facing organ failure [...]
Cannabix Technologies Deploys BreathLogix Alcohol Monitoring System with Lake County Community Corrections in Indiana's Second-Most Populous County
10/09/2026
VANCOUVER, British Columbia, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (the “Company or Cannabix”) developer of marijuana and alcohol breath testing technologies, is pleased to announce the [...]
Optimi Health to Initiate Phase 2 Clinical Trial Evaluating Psilocybin-Assisted Therapy for Major Depressive Disorder
10/09/2026
Health Canada-authorized trial to evaluate a single supervised dose of natural psilocybin, with dosing expected to be completed by the end of 2027 Up to 200 participants at sites across Canada, among the largest studies [...]
Tria Federal Promotes Diana Ceban to Chief Growth Officer to Align Growth Strategy Around the Healthcare Trilemma
10/09/2026
Ceban to lead enterprise growth centered on helping federal health agencies balance the competing pressures of cost, quality and access to care ARLINGTON, Va., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Tria Federal today [...]
Fortrea to Participate in September Investor Conferences
10/09/2026
DURHAM, N.C., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (“CRO”), today announced that CEO Anshul Thakral, CFO Jason Knoblauch, and SVP of Investor [...]
Scenic Biotech Appoints Renowned Neurology Drug Development Leader Dr. Judith Walker as Chief Medical Officer
10/09/2026
Dr. Walker joins to lead Scenic's transition into clinical development and shape its clinical strategy Lead program SC6177 is advancing toward the clinic with a first-in-class approach to restoring lysosomal function, a [...]
Teitur Trophics announces successful results from Phase I clinical trial of first-in-class Parkinson’s disease peptide TT-P34
10/09/2026
Study shows TT-P34 is safe and well tolerated in healthy volunteers and patients with early-stage Parkinson’s disease (PD), with pharmacokinetics confirming robust CNS exposure Early biomarker signals are consistent [...]
Rakovina Therapeutics Announces Appointment of Professor Petra Hamerlik to its Board of Directors
10/09/2026
Chair of Translational Neuro-Oncology at the University of Manchester, previously a member of the Company's Scientific Advisory Board, elected at the 2026 Annual General Meeting VANCOUVER, British Columbia, Sept. 10, [...]

Pages